Daily Archives: March 24, 2017

CHMP Backs Orphan Drug Refixia for Hemophilia B

Refixia (nonacog beta pegol) is a recombinant coagulation factor IX product for the treatment and prophylaxis of bleeding in patients aged 12 years and older with hemophilia B. International Approvals …read more

Significant increase in number of women tested for BRCA gene, but many high-risk patients are still missing out

Discovery of the BRCA genetic mutation in the mid-90s represented a breakthrough in breast and ovarian cancer prevention. …read more